Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research presented today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.
A new artificial intelligence model can predict people’s risk of multiple sclerosis years before diagnosis, potentially enabling quicker treatment, according to research revealed today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.
The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2023 Top Corporate Supporter Award.
At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a name change to the Association for Diagnostics & Laboratory Medicine.
Today, AACC—in collaboration with the American Diabetes Association (ADA)—released evidence-based guidelines to help diagnose and manage patients with diabetes using the latest laboratory-analysis tools. The guidelines replace previous versions published in 2002 and 2011. The new document features extensive updates on continuous glucose monitoring and more precise recommendations for measuring glucose and hemoglobin A1c, a marker of average blood glucose. Written by a cross-disciplinary team of medical experts, the guidelines provide specific, actionable advice that will enhance collaboration among healthcare professionals and improve care for millions of people.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the journal Clinical Chemistry received an impact factor of 9.3 —the second highest in the journal’s history—and the Journal of Applied Laboratory Medicine (JALM) received its first impact factor, of 2.0, according to the newly released 2022 Clarivate Journal Citation Reports.
Today, AACC—in collaboration with the National Kidney Foundation (NKF)—released guidance to reduce racial and gender disparities in the care of patients with chronic kidney disease (CKD). The document gives members of the healthcare team actionable, evidence-based tools to improve equity in kidney health, including recommendations for using an updated algorithm that does not disproportionately affect any one group of individuals.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Anthony A. Killeen, MB, BCh, PhD, MSc, has been elected to serve on the AACC board of directors as president-elect starting in August 2023. Following this, he will serve successive terms as the association’s president from August 2024-July 2025 and as past president from August 2025-July 2026. In addition, the AACC membership elected a new secretary and two new directors to the association’s board. They will take office in August 2023 along with the incoming president of AACC Academy and the incoming chair of the AACC Clinical Laboratory Scientists Council, both of whom will also serve on the board.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2023 AACC and AACC Academy Awards. Through this annual awards program, AACC strives to support laboratory medicine professionals in all stages of their careers and to build awareness of the essential role that clinical laboratory testing plays in improving patient health.
AACC has issued expert guidance on clinical testing for procalcitonin, a blood marker that helps detect serious bacterial infections and sepsis. By giving clinicians and laboratory professionals much-needed clarity on how to best use procalcitonin tests, the new guidelines could improve the treatment of critically ill patients and those with certain lower respiratory infections.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that MaryAnne Elma has assumed the position of chief science and policy officer for the association, effective today.
A first-of-its-kind study has established pediatric reference intervals for two common tests for cardiovascular disease. Published in AACC’s The Journal of Applied Laboratory Medicine, these findings are crucial to advancing diagnosis and treatment of heart conditions in children.
Scientists have developed a test that could greatly improve quality of life for infants with homocystinuria (HCU)—a congenital disease that, if not treated early, causes serious complications. Research demonstrating the efficacy of this test was published today in AACC’s Clinical Chemistry journal.
A little known but major challenge facing modern medicine is a lack of interoperability—i.e., the ability to effectively share clinical data, and especially clinical test results, between different healthcare organizations. In an effort to solve this issue, AACC has released a position statement today that urges HHS to fund interoperability pilot programs and to incentivize its adoption, which would vastly improve the quality of care patients receive.
With the goal of improving cervical cancer care, AACC has published a new guidance document with expert recommendations on detecting this cancer. The guidance aims to update healthcare and laboratory medicine professionals on the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients.
In this special Data Science Issue, AACC’s The Journal of Applied Laboratory Medicine highlights the groundbreaking work that laboratory medicine experts are doing to advance patient care through data analytics and to make this game-changing technology a routine part of healthcare.
Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC’s The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
AACC applauds the decision of the United States Congress to exclude the Verifying Accurate Leading-edge IVCT Development (VALID) Act from its end of year omnibus bill.
A first-of-its-kind study published today in AACC’s Clinical Chemistry journal shows that a novel drug test detects a new class of synthetic cannabinoids called OXIZIDs. This test could enable drug enforcement agencies to identify OXIZID users and could play a critical role in efforts to stop the spread of these drugs.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right